Trigone Pharma

Trigone Pharma is dedicated to developing safe and effective localized treatments for urinary tract diseases. The first product we are developing addresses the unmet need for an effective and localized treatment for interstitial cystitis/bladder pain syndrome (IC/BPS). This chronic bladder condition causes recurring pain and pressure in the bladder and pelvic region, often accompanied by urgent and frequent urination needs. Trigone Pharma’s product is designed to prolong drug contact with urothelial tissues. By enhancing sustained drug release and increasing its dwell time in the bladder, localized treatment becomes a highly efficient therapeutic option, ensuring safe outcomes and improving patient compliance. Our product incorporates well-established compliance components, providing effective, safe, easy-to-use, and user-friendly treatment management at 1-4 week intervals.